Skip to main content
. 2021 Apr 7;12:648081. doi: 10.3389/fneur.2021.648081

Figure 3.

Figure 3

The distributions and percentages of in situ atherosclerotic thrombosis patients in different predictive scale risk categories. (A) The derivation cohort (consecutive). (B) the validation cohort (consecutive). (C) the derivation cohort (dichotomous). (D) the validation cohort (dichotomous). ISAT, in situ atherosclerotic thrombosis.